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Abstract 
Despite its high prevalence, anemia is often undetected due to the invasiveness and cost of 
screening and diagnostic tests. Though some non-invasive approaches have been developed, 
they are less accurate than invasive methods, resulting in an unmet need for more accurate 
non-invasive methods. Here, we show that deep learning-based algorithms can detect anemia 
and quantify several related blood measurements using retinal fundus images both in isolation 
and in combination with basic metadata such as patient demographics. On a validation dataset 
of 11,388 patients from the UK Biobank, our algorithms achieved a mean absolute error of 0.63 
g/dL (95% confidence interval (CI) 0.62-0.64) in quantifying hemoglobin concentration and an 
area under receiver operating characteristic curve (AUC) of 0.88 (95% CI 0.86-0.89) in detecting 
anemia. This work shows the potential of automated non-invasive anemia screening based on 
fundus images, particularly in diabetic patients, who may have regular retinal imaging and are at 
increased risk of further morbidity and mortality from anemia. 
 
 
 
 
 
 
  
Introduction 
Anemia is a public health problem affecting an estimated 1.62 billion people 1 . In 2011, 
29% of non-pregnant women worldwide were affected by anemia 2 . As a major contributor to 
global burden of disease, anemia has far-reaching consequences for work and productivity and 
quality of life 1,3,4 . As anemia is usually correctable 5 , timely detection and intervention are key. 
The most reliable indicator of anemia is hemoglobin concentration (Hb) 1 , which is traditionally 
measured using a venous or capillary blood sample. However, these procedures are invasive 
and painful, can cause infection of patients and healthcare workers, and generate biohazardous 
waste 6 . Thus, there is a clear need for a non-invasive procedure. 
Several non-invasive methods of estimating Hb are now available. Traditionally, 
subjective assessment of pallor of the conjunctiva, nail beds, tongue, and palms have been 
used as clinical signs indicating the presence of severe anemia, with a wide range of estimated 
sensitivities and specificities 7,8 . Recently, it was reported that Hb can be estimated with high 
accuracy using automated algorithms from the color of fingernail beds in digital photographs 
taken by smartphones 9 . However, the algorithms were based on manually selected regions of 
interest on the fingernails, and their robustness and real-world performance remains to be 
assessed. Another two methods, occlusion spectroscopy and pulse-co-oximetry, use 
spectrophotometric sensors that non-invasively assess Hb by measuring light transmission 
through the tissue 10,11 . These non-invasive methods are less accurate than the gold standard of 
venous blood laboratory analysis 12  and represent trade-offs between invasiveness, time, cost, 
and accuracy 9 .  
Interestingly, anemia of sufficient severity has been known to manifest characteristic 
signs in the fundus of the eye 13 , and 20% of anemia patients have reported to develop 
extravascular lesions, with severity of anemia related to venous tortuosity 14 . Retinopathy is 
observed in 28.3% of patients with anemia and/or thrombocytopenia, and low Hb level was 
associated with the presence of retinopathy 14 . However, the low prevalence of retinopathy 
among anemic patients limits its potential sensitivity as a stand-alone diagnostic feature, and 
fundus photographs have not been used to either detect anemia or quantify more precise Hb 
levels. 
In this work, we explore the hypothesis that Hb can be quantified using noninvasive 
fundus photographs and deep learning (DL). DL has been previously shown to be highly 
effective in extracting information from images 15 . In ophthalmology, DL algorithms can detect 
eye conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma 
with accuracy comparable to human experts 16–21 . Additionally, some previously-unknown 
information can be extracted from fundus images, such as refractive error 22 , age, sex, and 
cardiovascular risk 23 . Extending this, we show that DL can be leveraged to quantify Hb and 
detect anemia. 
Results 
This study was conducted using data from UK Biobank 24 . In total, 114,205 fundus 
images from 57,163 patients were included in this study. In the validation set, the median age of 
the patients was 57.9 (50.0-63.8, interquartile range) years, 54.9% were female, and 91.1% 
were White (Table 1). Among all the patients, 3.7% had anemia, with Hb ranging from 6.4 [g/dL] 
to 19.6 [g/dL]. Additional patient demographics are summarized in Table 1. 
Results of many blood tests including Hb are correlated with patients’ metadata such as 
demographics. Some of these metadata, such as age and gender have previously been shown 
to be predictable using fundus images 23 . Therefore to later ensure that our predictors were not 
solely predicting Hb measurements via age and gender, we first developed baseline linear 
regression models using these metadata (metadata-only model). Next, we developed 
deep-learning based models using fundus images (fundus-only model). Lastly, we hypothesized 
that a model utilizing both types of input data may be even more accurate and thus developed 
combined models that use both metadata and fundus images (combined model). 
First, we compared the performance of metadata-only, fundus-only, and combined 
models trained to predict Hb, hematocrit (HCT), and red blood cell count (RBC), which are 
correlated with each other and related to anemia (Fig. 1). The mean absolute error (MAE) for 
predicting Hb by the metadata-only model was 0.73 (95% confidence interval (CI): 0.72-0.74) 
g/dL. MAE was 0.67 (95% CI: 0.66-0.68) g/dL for the fundus-only model and 0.63 (95% CI: 
0.62-0.64) g/dL for the combined model. The performance of predicting HCT and RBC follow a 
similar trend across the three models. Thus, the combined model predicted Hb, HCT, and RBC 
more accurately than either fundus-only or metadata-only models, indicating that both metadata 
and fundus images are important for the accurate prediction. 
Additionally, we investigated whether errors made by the model were patient-specific. In 
the test set, 342 patients had two visits with both fundus images and a Hb measurement. We 
applied the combined model to the two visits and found that the residual error was correlated 
between multiple visits over time by the same patient (Fig. 2, Pearson’s correlation coefficient r 
= 0.38 (95% CI: 0.18-0.65)). 
Next, we examined if fundus images can be used to predict anemia by developing a DL 
based classification model to directly predict whether a patient is anemic. Using World Health 
Organization’s (WHO) Hb cutoffs for anemia, we trained the models for three binary 
classification tasks (anemia, moderate anemia, approximate anemia, see Methods). For all of 
them, the combined model and the fundus-only model performed better than metadata-only 
model (Fig. 3, Table 2). The area-under-receiver-operating-characteristic-curve (AUC) for 
detecting anemia was 0.73 (95% CI: 0.72-0.75) for the metadata-only model, 0.87 (95% CI: 
0.85-0.89) for the fundus-only model, and 0.88 (95% CI: 0.86-0.89) for the combined model 
(Fig. 3a). AUC for detecting moderate anemia was 0.79 (95% CI: 0.76-0.82) for the 
metadata-only model, 0.95 (95% CI: 0.93-0.97) for the fundus-only model, and 0.95 (95% CI: 
0.93-0.97) for the combined model (Fig. 3b). The sensitivity to detect moderate anemia was 
57.3% (95% CI: 47.6-70.5) for the metadata-only model, 91.2% (95% CI: 87.7-94.4) for the 
fundus-only model, and 92.3% (95% CI: 88.1-95.9) for the combined model, when the specificity 
was 80% (Table 2). These results show that both the fundus-only model and the combined 
model successfully extracted information about anemia from fundus images, and it supports the 
hypothesis that DL model can help detect anemia using fundus images. 
We further investigated the importance of different anatomic features to the prediction by 
“ablating” different aspects of the images during both model training and validation (Fig. 4 and 
5). Most notably, when the top and bottom parts of the images were masked, the performance 
started to decline only after about 80% of each image was masked (Fig. 4a, b). Masking the 
horizontal stripes through the middle of the images decreased the performance after about 20% 
of each image was masked (Fig. 4d, e). When either the circular central core or the outer rim of 
the image was masked, the performance started to decline after about 40% was masked (Fig. 
4g, h, j, k). The biggest drop in AUC when 10% of the image was masked occurred while 
masking the central horizontal stripe: an AUC drop of about 3%. We also examined the effect of 
Gaussian blurs (Fig. 5), and found that applying a Gaussian blur with σ = 8 pixels decreased the 
AUC for predicting moderate anemia from 0.92 to 0.83 (Fig. 5c). 
Lastly, we examined if other components of the complete blood count (CBC) could be 
predicted from fundus images. Anemia is diagnosed based on blood Hb measurements, which 
is often measured as a part of the CBC. In addition to Hb, HCT, and RBC, other measurements 
such as the mean corpuscular volume (MCV) also help to diagnose anemia and identify the 
subtype. Since the different components of CBC are measured on separate scales, we 
compared the model’s performance across tests with the  R 2  coefficient of determination.  The 
combined model was not able to predict MCV with high accuracy, with a low  R 2  of 0.12. On the 
other hand, the model predicted the three anemia-related measurements (Hb, HCT, and RBC) 
most accurately,  R 2  values of 0.52, 0.49, and 0.36, respectively (Table S1) . 
 
 
Discussion  
This study shows that a DL-based approach leveraging retinal fundus images and 
metadata can both detect anemia and quantify Hb measurements, potentially enabling 
automated anemia screening using fundus images. 
To help put the accuracy of our and other non-invasive anemia detection methods in 
context, it can be useful to consider the variability of the ground truth itself 25,26 . As consistent 
with other studies, the ground truth in this study was Hb measured by laboratory hematology 
analyzers 27 . The standard deviation of the difference between hematology analyzers and the 
hemoglobincyanide method (HiCN, the gold standard for Hb measurement for research) was 
0.18 g/dL 28 , equivalent to MAE of 0.14 g/dL. Thus a portion of our model’s MAE (0.63 g/dL) may 
be attributable to variability in the laboratory Hb measurement. The accuracy of our approach is 
also comparable to invasive (pooled standard deviation of difference was 0.64 g/dL 29 , equivalent 
to MAE of 0.51 g/dL) and non-invasive point-of-care devices (pooled standard deviation was 1.4 
g/dL 29 , 30 , equivalent to MAE of 1.1 g/dL), and non-invasive smartphone-based application (95% 
limits of agreement was 2.4 g/dL 9 , equivalent to MAE of 0.96 g/dL) (Table 3). 
In addition, because fundus photographs are routinely captured as part of teleretinal 
screening for diabetic retinopathy 31–33 , the ability to predict Hb from these photographs may 
provide a convenient way for anemia screening in diabetics with minimal additional cost. The 
clinical motivation and utility of anemia screening in diabetics is many-fold. First, diabetics can 
develop chronic kidney disease, which leads to renal anemia 34 . Second, in patients with diabetic 
kidney disease, renal anemia often develops earlier than other forms of nephropathy 35–38 . Even 
in the absence of nephropathy, Hb in diabetic patients tends to decrease over time 34,39 . 
Additionally, the correction of anemia improves the quality of life and may reduce diabetic 
complications 38 . Finally, from an ophthalmic standpoint, anemia is an independent risk factor for 
developing high-risk proliferative diabetic retinopathy 40 . Thus, regular screening for anemia is 
recommended for diabetic patients 40–42 . 
Beyond the initial diagnosis, subsequent Hb measurements are used to track 
progression of anemia and response to treatment. In addition, even without a diagnosis of 
anemia, rapid decrease in Hb may indicate existence or onset of an underlying disease. Thus, 
in addition to the Hb level at one visit, the difference in Hb across visits is clinically important. 
Interestingly, our prediction error between multiple visits of the same patient was correlated, 
showing that some component of the error is patient-specific. When comparing the differences 
in predictions across multiple visits, the patient-specific components cancel out. Thus, our 
approach may provide additional value in monitoring the trend in Hb. This premise will be further 
supported by future work, such as assessing the time delay between true Hb changes and 
changes in Hb predicted by the algorithm using fundus images: whether the prediction of the 
model reflects instantaneous Hb or the average Hb over a certain time window. Understanding 
how the algorithm works would help answer this question. If the algorithm is quantifying the 
degree of pallor in the fundus, we would expect minimal to no time delays in the order of 
minutes or hours. On the other hand, if the algorithm is examining features in microvasculature 
that develop over time, the time delay may be weeks or months. Investigating how the algorithm 
reflects recent Hb changes and validating it with multiple measurements over time will be an 
important step toward determining clinical use cases of the algorithm. 
To understand the underlying mechanisms of the model, we examined how the 
performance was affected by applying image ablation. First, we hypothesized that if the 
algorithm was based on the degree of pallor of the fundus as a whole, applying a Gaussian blur 
would have little effect on the performance. However, applying a Gaussian blur decreased the 
model performance, indicating that the model was dependent on the fine spatial features of the 
fundus images. In addition, we applied various masking methods to examine which portions of 
the fundus images are relevant to the model performance. Masking the top and bottom parts 
had little to no effect on the model performance, showing that the information contained in those 
areas was redundant. Masking the central core, which includes macula, had less effect than 
masking the horizontal stripe through the middle part, which includes both macula and disc. 
These results suggest that fine spatial features around the optic disc are crucial. Future studies 
could investigate this hypothesis further using multiple explanation techniques. 
Another aspect of understanding the algorithm is whether it is detecting anemia or the 
underlying pathophysiology specific to each subtype of anemia. Anemia has multiple subtypes, 
and each has a different underlying etiology and requires different management. Other 
components of the CBC, in particular the MCV (average volume of red blood cells), are used to 
differentiate between the subtypes. For example, while iron-deficiency anemia typically presents 
with normal MCV, vitamin B12 or folate deficiency typically presents with elevated MCV, and 
anemia of chronic disease and thalassemia presents with decreased MCV. Thus, we 
hypothesized that if fundus images contained information about subtype-specific 
pathophysiology, the algorithm would be able to predict CBC results beyond Hb, RBC and HCT. 
However, the results did not support this hypothesis, indicating that the algorithm may be 
responding to features associated with the lack of hemoglobin itself. These results also illustrate 
that the algorithms may be useful for screening, but not for diagnosis. Patients would require 
referral and follow-up examinations such as blood tests before treatment. 
When developing machine-learning-based algorithms, it is crucial to include a broad 
range of examples in the training set so that the developed algorithm generalize well in various 
settings. One of the limitations of our study is that we have used a dataset from a single source. 
For example, ethnicity is highly biased towards Caucasians in the UK Biobank dataset. Training 
and validating on multiple diverse datasets will be important for creating a generalizable 
algorithm. 
To conclude, we showed that anemia and Hb level can be predicted from fundus images. 
Further research is warranted to examine if the approach is useful for scalable screening of 
anemia. 
 
Methods 
Study participants 
The dataset for this study consisted of fundus images obtained from the UK Biobank 24 , 
an observational study that recruited 500,000 participants, aged 40-69, across the United 
Kingdom between 2006 and 2010. The study was reviewed and approved by the North West 
Multi-Centre Research Ethics Committee. Each participant was consented and went through a 
series of health measurements and questionnaires. Each participant also provided blood, urine, 
and saliva samples. Approximately 70,000 patients also subsequently underwent 
ophthalmological examinations with paired retinal fundus and optical coherence tomography 
(OCT) imaging using a Topcon 3D OCT 1000 Mk2 (Topcon Corporation, Tokyo, Japan). Only 
retinal fundus images were included in this study. About 12% of the patients were excluded due 
to poor image quality as described previously 22 . Only patients with at least one fundus image 
paired with Hb measurement were included in this study (n=57,163). For complete blood count 
(CBC) analysis, only the patients who had all the CBC components measured were included 
(n=53,473). If a patient had multiple visits with paired fundus images and Hb measurement, only 
the first visit was included, except in the multiple-visit analysis described. The study was 
reviewed and approved by the North West Multi-Centre Research Ethics Committee. We 
randomly divided this dataset into a development set to develop our models (80%) and a 
validation set to assess our model’s performance (20%) after stratifying patients by their gender 
and age. The validation set was not accessed during model development. 10% of the data in 
the development dataset (“tuning dataset”) was used during model development for tuning 
hyper parameters such as learning rate and criterion for early stopping, with the remaining 70% 
(“training dataset”) used for training the parameters of the neural networks. 
Definitions of anemia 
Using WHO’s guidelines 43 , we used three sets of cut-offs based on Hb measurements: 
12 g/dL for women and 13 g/dL for men (anemia), and 11 g/dL (moderate anemia). In addition, 
we assessed our results using a previously described gender neutral average anemia cutoff at 
12.5 g/dL 9  for both men and women, which we call “approximate anemia”. 
Categories of predictive models 
In this study, we made two different types of predictions: continuous values (e.g. Hb or 
hematocrit; henceforth “regression tasks”), categorical values (e.g. presence or absence of 
anemia; henceforth “classification tasks”).  Though a single model can in principle be trained for 
both regression tasks and multiple classification tasks, separate models were trained for 
regression tasks and classification tasks to keep the loss functions on a consistent scale.  For 
each of these tasks, we compared the ability of three different categories of prediction models, 
each with a different set of input data. As a baseline, we used linear regression for regression 
tasks and logistic regression for classification tasks. These linear and logistic regression models 
used only  demographic and clinical information (“metadata”, which are ethnicity, age, sex, 
current smoking status, systolic and diastolic blood pressure, pulse rate, height, weight, and 
body mass index ( BMI)). We will refer to these as “metadata models” . Our second type of 
models used a deep convolutional neural network (details in the next section) with fundus 
images as input  (“fundus-only models”). Our third and last type of models used both metadata 
and fundus images as input; the metadata was concatenated with the output of the Inception-v4 
architecture 44  before the fully connected layer (“combined models”). Specifically, the fundus 
images were used as an input to a deep convolutional neural network (same structure as the 
fundus-only model), and the output of the convolutional neural network and metadata were 
provided to the combined model before the final layer (i.e., a “late fusion” model). The fully 
connected layer of fundus-only models and combined models had one output for each 
regression task and multiple outputs for each classification task (each output corresponds to 
each class).  
Development of the deep learning algorithms 
Fundus images were preprocessed as previously described 23 , while the input metadata 
and continuous output values (e.g. Hb) were standardized to have zero mean and unit variance. 
Using these data, a deep convolutional neural network with the Inception-v4 architecture 44  was 
developed and trained in TensorFlow 45 . The Inception-v4 network was initialized using 
parameters from a network pre-trained to classify objects in the ImageNet dataset 46 , and the 
weights on the auxiliary connections from metadata were randomly initialized. Mean squared 
error was used as a loss function for regression tasks, and cross entropy was used for 
classification tasks. The models were trained with mini-batch stochastic gradient descent with 
momentum 47  with linear warm up 48  using Google Tensor Processing Unit (TPU) accelerators 49 
(see supplementary methods). The learning rate was chosen to minimize the error in the tuning 
dataset. Since our network had a large number of parameters ( 43 million), to prevent overfitting 
training was terminated before convergence using early stopping 50  based on the performance 
on the tuning  dataset. An ensemble of 10 networks 51  was trained on the same development set, 
and the outputs were averaged to yield the final prediction. For each patient, the final prediction 
was the average across both eyes. 
Evaluating the algorithms 
To evaluate the model performance for continuous predictions, we used the mean 
absolute error (MAE) and  R 2 . For binary classification, we used the area under receiver 
operating characteristic curve (AUC) and sensitivity at various levels of specificity. To obtain 
95% confidence intervals for these performance metrics, we used the non-parametric bootstrap 
procedure with 2,000 samples and reported the 2.5 and 97.5 percentiles. 
Ablation analysis 
While applying ablation during both training and validation, we trained the fundus-only 
model for classification tasks and assessed the performance (AUC for predicting anemia and 
moderate anemia) of the model without ensembling or averaging across eyes. For each ablation 
method (e.g. masking 20% of the fundus at the center), 3 networks were trained, and the 
performance metrics were averaged across 3 networks. 
Code availability 
The machine-learning models were developed using standard model libraries and scripts 
in TensorFlow 45 . Custom code was specific to our computing infrastructure and mainly used for 
data input/output and parallelization across computers. 
Data availability 
The data that support the findings of this study are available, with restrictions, from UK 
Biobank 24 .  
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Tables and figures 
Table 1.  Basic characteristics of the development datasets and the validation dataset.  
 Development Datasets Validation Dataset 
 Training dataset  Tuning dataset  
Total no. images 80,006 11,457 22,742 
No. of patients 40,041 5,734 11,388 
Age (years)* 57.9 (50.0-63.7) 58.0 (49.9-63.7) 57.9 (50.0-63.8) 
Females (%) 21,944 (54.8%) 3,152 (55.0%) 6,255 (54.9%) 
Ethnicity (%) 
     Black 468 (1.2%) 74 (1.3%) 145 (1.3%) 
     Asian 1,330 (3.3%) 192 (3.3%) 404 (3.5%) 
     White 36,606 (91.4%) 5,247 (91.5%) 10,369 (91.1%) 
     Other 1,637 (4.1%) 221 (3.9%) 470 (4.1%) 
Current Smoker (%) 3,794 (9.5%) 544 (9.5%) 1,120 (9.8%) 
Body mass index (kg/m 2 )* 26.6 (24.0-29.7) 26.7 (24.1-29.9) 26.6 (24.1-29.7) 
Height (cm)* 168 (162-176) 168 (162-176) 168 (162-175) 
Weight (kg)* 76.3 (66.2-87.5) 76.7 (66.4-87.6) 76.3 (66.4-87.8) 
Heart rate (bpm)* 67.5 (61.0-74.5) 67.5 (60.5-75.0) 67.0 (61.0-74.0) 
Systolic blood pressure 
(mmHg)* 
135 (124-148) 135 (124-148) 136 (124-148) 
Diastolic blood pressure 
(mmHg)* 
82 (75-88) 82 (75-89) 82 (75-88) 
Hemoglobin concentration 
(g/dL)* 
14.3 (13.4-15.2) 14.3 (13.4-15.1) 14.2 (13.4-15.1) 
Distribution of Anemia levels 
None 38,628 (96.5%) 5,539 (96.6%) 10,949 (96.1%) 
Mild 1,134 (2.8%) 164 (2.9%) 347 (3.0%) 
Moderate 267 (0.7%) 31 (0.5%) 90 (0.8%) 
Severe  12 (0.0%) 0 (0.0%) 2 (0.0%) 
* results are presented as median (interquartile range). bpm, beats per minute. 
 
 
 
  
 Table 2. Sensitivity at various levels of specificity. 
 Specificity 
70% 80% 90% 
Anemia 
  Metadata-only 63.3% (60.2-66.3) 52.5% (48.6-56.1) 32.0% (23.9-36.4) 
  Fundus-only 86.0% (83.9-88.4) 78.5% (74.5-82.4) 64.0% (56.6-69.2) 
  Combined 86.6% (83.8-88.4) 79.4% (75.3-82.9)) 65.2% (60.5-71.1) 
Moderate anemia 
  Metadata-only 78.0% (66.0-80.7) 57.3% (47.6-70.5) 39.7% (25.0-47.8) 
  Fundus-only 94.8% (92.8-96.8) 91.2% (87.7-94.4) 86.9% (80.8-90.8) 
  Combined 96.7% (93.0-97.8) 92.3% (88.1-95.9) 84.2% (71.7-91.3) 
Approximate anemia 
  Metadata-only 73.5% (72.2-75.1) 65.8% (62.9-67.9) 52.9% (50.8-55.2) 
  Fundus-only 84.8% (82.6-86.9) 76.4% (73.1-79.1) 63.5% (59.2-67.5) 
  Combined 86.1% (85.0-88.0) 80.9% (78.6-83.1) 69.7% (66.9-73.6) 
   Sensitivity is presented with 95% confidence intervals.  
  Bold indicates the highest sensitivity among the models at each condition.  
Table 3. Accuracy of different methods to measure hemoglobin concentration. 
 
 Standard deviation of 
difference 
95% Limits of 
agreement 
(Estimated) MAE (*) 
Hematology 
analyzer 28 
0.18 g/dL 0.37 g/dL 0.14 g/dL (*) 
Invasive 
point-of-care 
devices 29 
0.64 g/dL NA 0.51 g/dL (*) 
Non-invasive 
point-of-care 
devices 29 , 30 
1.4 g/dL NA 1.1 g/dL (*) 
Smartphone-based 
method 9 
NA 2.4 g/dL 0.96 g/dL (*) 
Our method 
(combined model) 
0.82 g/dL (0.80-0.85) 1.58 g/dL (1.54-1.64) 0.63 g/dL (0.62-0.64) 
  (*) Mean absolute error (MAE) was estimated assuming that the error has a Gaussian 
distribution. Hematology analyzer was compared with hemoglobincyanide method. Other 
methods are compared with hematology analyzer. For the combined model, the results are 
shown with 95% confidence intervals. 
 
  
 Figure 1. Prediction of hemoglobin concentration, hematocrit and red blood cell count. 
a , Each blue dot represents each patient’s measured hemoglobin concentration and predicted 
value from the metadata-only model. Gray line represents an identity line, where measured 
values equal predicted values. Inset text shows mean absolute error (MAE) with 95% 
confidence intervals (n=11,388).  b ,  same as  a for the fundus-only model.  c , same as  a for the 
combined model.  d - f , same as  a - c for hematocrit.  g - i , same as  a - c for red blood cell count.  
  
Figure 2. Correlation between residual errors of the combined model from multiple 
visits. 
Each blue dot represents each patient (n=342). Residual error is the difference between 
measured hemoglobin concentration and prediction by the combined model. Gray line 
represents an identity line. Pearson’s correlation coefficient r = 0.38 (95% confidence interval: 
0.18-0.65).  
 Figure 3. Prediction of anemia classifications. 
a ,  Receiver operating characteristic (ROC) curves for detecting anemia by the metadata-only 
model (black line), the fundus-only model (blue line), and the combined model (red line). Area 
under the curve (AUC) for each model is shown with 95% confidence intervals (n=11,388).  b , 
ROC curves and AUCs for detecting moderate anemia.  c , ROC curves and AUCs for detecting 
approximate anemia (Methods). 
 
 
 
   
 Figure 4. Effects of masking parts of the image on the prediction of anemia and 
moderate anemia. 
The masking was applied during both training and validation.  a , Masking the top and bottom 
parts of the images. Arrowheads correspond to examples shown in  b and  c .  b and  c , Example 
masked images.  d - f , Similar to  a - c , but for masking a horizontal stripe through the middle of the 
images.  g - i , Similar to  a - c , but for masking the outer rim of the images.  j - l , Similar to  a - c , but for 
masking a central core of the images. AUC, area under receiver operating characteristic curve.  
    
Figure 5. Effects of removing high-frequency information using Gaussian blur on the 
prediction of anemia and moderate anemia. 
The ablation was applied during both training and validation.  a , Model performance as a 
function of a Gaussian blur amount. Arrowheads correspond to examples shown in  b - d . b - d , 
Example images with varying blur amounts. σ, standard deviation of the Gaussian kernel used 
for a blur, which was applied after images were resized to 587 pixel  × 587 pixel. AUC, area 
under receiver operating characteristic curve.  
Supplementary information 
Supplementary methods 
We trained each model on a single Google TPUv2 unit (8 cores across 4 chips, 8 GB memory 
per core, 180 teraFLOPS in total) with the following hyperparameters: 
– Inception-v4 architecture 
– Input image resolution: 587 × 587 
– Learning rate: 0.0008 
– Learning rate was initially 0.0001, and linearly increased at each step until it reached 
0.0008 after 3 epochs 48 . 
– Batch size: 64 (8 per core, and 8 cores ran synchronously) 
– Batch size for batch normalization: 8 (batch normalization was performed at each core) 
– Weight decay: 0.00004 
–  Mini-batch stochastic gradient descent  optimizer with momentum 47 
– Data augmentation (in order): 
    • Random vertical and horizontal reflections 
    • Random brightness changes with a max delta of 0.1147528 
    • Random saturation changes between 0.5597273 and 1.2748845 
    • Random hue changes between -0.0251488 and 0.0251488 
    • Random contrast changes between 0.9996807 and 1.7704824 
– For classification tasks, each class was weighted in proportion to the number of examples of 
the class to the power of -0.9. 
– Model evaluations were performed using a running average of parameters, with an 
exponential decay factor of 0.9999. 
 
  
 Table S1. Prediction of complete blood count components. 
The metadata-only model, the fundus-only model, and the combined model were trained to 
predict all the complete blood components. Note that the difference from Figure 1 is due to 
being trained for additional components at the same time and using a smaller subset of patients 
who had all the components measured.  R 2 , coefficient of determination. 
 
 
